Verizon exec sells 1,100 shares under plan

Kyle Malady’s Rule 10b5-1 plan led to his Sept. 1, 2026 sale of 1,100 VZ shares at $50.50, after which he still held 107,666 direct shares.

Rhea-AI Filing Summary

VERIZON COMMUNICATIONS INC (VZ) executive Kyle Malady, EVP and Group CEO–VZ Business, reported selling 1,100 shares of common stock on September 1, 2026 at $50.50 per share in an open-market transaction. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026. Following this sale, he directly holds 107,666 shares and indirectly holds 20,196 shares through a 401(k) plan.

Insider Trade Summary 10b5-1

Net Seller: 1,100 shares

Net Sell 2 txns

Insider Malady Kyle

Role EVP and Group CEO-VZ Business

Sold 1,100 shs ($56K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,100	$50.50	$56K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 107,666 shares (Direct); Common Stock — 20,196 shares (Indirect, By 401(k))

Footnotes (1)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Key Figures

Shares sold: 1,100 shares Sale price per share: $50.50 per share Direct holdings after transaction: 107,666 shares +3 more

6 metrics

Shares sold 1,100 shares Open-market sale of Verizon common stock on September 1, 2026

Sale price per share $50.50 per share Price for the 1,100 Verizon shares sold on September 1, 2026

Direct holdings after transaction 107,666 shares Direct Verizon common stock owned by Kyle Malady after the sale

Indirect holdings after transaction 20,196 shares Indirect Verizon common stock held by Kyle Malady through a 401(k) plan

Rule 10b5-1 adoption date May 18, 2026 Adoption date of trading plan governing the reported sale

Net shares sold 1,100 shares Net change in buy/sell activity reported in this Form 4

Key Terms

Rule 10b5-1 trading plan, Form 4, 401(k)

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The Form 4 reports only a sale of 1,100 shares of common stock"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

401(k) financial

"indirectly holds 20,196 shares through a 401(k) plan"

A 401(k) is a type of retirement savings plan offered by employers that allows workers to set aside a portion of their paycheck before taxes are taken out. The money saved in a 401(k) can grow over time through investments, helping individuals build funds for their future retirement. It matters to investors because it provides a tax-advantaged way to save and invest for long-term financial security.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VZ executive Kyle Malady report on this Form 4?

Kyle Malady reported a sale of 1,100 shares of Verizon Communications Inc. common stock on September 1, 2026, executed in an open-market transaction at $50.50 per share.

Was the VZ insider sale by Kyle Malady made under a Rule 10b5-1 plan?

Yes. The filing states the 1,100-share sale on September 1, 2026 was executed pursuant to a Rule 10b5-1 trading plan adopted by Kyle Malady on May 18, 2026.

How many VZ shares does Kyle Malady hold after the reported transaction?

After the sale, Kyle Malady directly holds 107,666 shares of Verizon common stock and indirectly holds 20,196 shares through a 401(k) plan, according to the Form 4.

What price did the VZ shares sell for in Kyle Malady’s September 1, 2026 transaction?

The reported sale price was $50.50 per share for the 1,100 shares of Verizon Communications Inc. common stock sold on September 1, 2026.

Does the Form 4 show any option exercises or derivative transactions for VZ?

No. The Form 4 reports only a sale of 1,100 shares of common stock and an updated indirect holding of 20,196 shares via a 401(k). It shows no derivative transactions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 12:50 PM EDT Accepted by SEC EDGAR 09/02/2026 - 12:50 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)		1,100	D	$50.5	107,666	D
Common Stock								20,196	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Remarks:

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)